 | • レポートコード：MRC2-11QY04717 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は頭頸部扁平上皮がん (HNSCC)治療のグローバル市場について調査・分析したレポートです。種類別（唾液腺、口腔および中咽頭、鼻腔および副鼻腔、鼻咽頭、喉頭および下咽頭）市場規模、用途別（病院、専門クリニック、外来外科センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別頭頸部扁平上皮がん (HNSCC)治療の競争状況、市場シェア ・世界の頭頸部扁平上皮がん (HNSCC)治療市場：種類別市場規模 2015年-2020年（唾液腺、口腔および中咽頭、鼻腔および副鼻腔、鼻咽頭、喉頭および下咽頭） ・世界の頭頸部扁平上皮がん (HNSCC)治療市場：種類別市場規模予測 2021年-2026年（唾液腺、口腔および中咽頭、鼻腔および副鼻腔、鼻咽頭、喉頭および下咽頭） ・世界の頭頸部扁平上皮がん (HNSCC)治療市場：用途別市場規模 2015年-2020年（病院、専門クリニック、外来外科センター） ・世界の頭頸部扁平上皮がん (HNSCC)治療市場：用途別市場規模予測 2021年-2026年（病院、専門クリニック、外来外科センター） ・北米の頭頸部扁平上皮がん (HNSCC)治療市場分析：米国、カナダ ・ヨーロッパの頭頸部扁平上皮がん (HNSCC)治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの頭頸部扁平上皮がん (HNSCC)治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の頭頸部扁平上皮がん (HNSCC)治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの頭頸部扁平上皮がん (HNSCC)治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sanofi、Pfizer、Eli Lilly、Bristol-Myers Squibb、Merck、Bayer、Fresenius、Teva Pharmaceutical、AB SCIENCE、AbbVie、Acceleron Pharma、Astellas Pharma、AstraZeneca、Sumitomo Dainippon Pharma、GENERAL ELECTRIC COMPANY ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Head and neck cancer usually occurs in the squamous cells present inside the mouth, nose and throat. These squamous cells are usually known as squamous cell carcinoma of the head and neck.
Market Analysis and Insights: Global Squamous Cell Carcinoma of the Head and Neck Treatment Market
The global Squamous Cell Carcinoma of the Head and Neck Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Squamous Cell Carcinoma of the Head and Neck Treatment Scope and Market Size
Squamous Cell Carcinoma of the Head and Neck Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Squamous Cell Carcinoma of the Head and Neck Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Sanofi
Pfizer
Eli Lilly
Bristol-Myers Squibb
Merck
Bayer
Fresenius
Teva Pharmaceutical
AB SCIENCE
AbbVie
Acceleron Pharma
Astellas Pharma
AstraZeneca
Sumitomo Dainippon Pharma
GENERAL ELECTRIC COMPANY
Market segment by Type, the product can be split into
Salivary Gland
Oral & Oropharyngeal
Nasal Cavity & Paranasal Sinus
Nasopharyngeal
Laryngeal & Hypo pharyngeal
Market segment by Application, split into
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Squamous Cell Carcinoma of the Head and Neck Treatment Revenue
1.4 Market by Type
1.4.1 Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Salivary Gland
1.4.3 Oral & Oropharyngeal
1.4.4 Nasal Cavity & Paranasal Sinus
1.4.5 Nasopharyngeal
1.4.6 Laryngeal & Hypo pharyngeal
1.5 Market by Application
1.5.1 Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Specialty Clinics
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Perspective (2015-2026)
2.2 Global Squamous Cell Carcinoma of the Head and Neck Treatment Growth Trends by Regions
2.2.1 Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Squamous Cell Carcinoma of the Head and Neck Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Squamous Cell Carcinoma of the Head and Neck Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Squamous Cell Carcinoma of the Head and Neck Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Squamous Cell Carcinoma of the Head and Neck Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Squamous Cell Carcinoma of the Head and Neck Treatment Players by Market Size
3.1.1 Global Top Squamous Cell Carcinoma of the Head and Neck Treatment Players by Revenue (2015-2020)
3.1.2 Global Squamous Cell Carcinoma of the Head and Neck Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Concentration Ratio
3.2.1 Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Squamous Cell Carcinoma of the Head and Neck Treatment Revenue in 2019
3.3 Squamous Cell Carcinoma of the Head and Neck Treatment Key Players Head office and Area Served
3.4 Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Product Solution and Service
3.5 Date of Enter into Squamous Cell Carcinoma of the Head and Neck Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Squamous Cell Carcinoma of the Head and Neck Treatment Historic Market Size by Type (2015-2020)
4.2 Global Squamous Cell Carcinoma of the Head and Neck Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2015-2020)
5.2 Global Squamous Cell Carcinoma of the Head and Neck Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size (2015-2020)
6.2 Squamous Cell Carcinoma of the Head and Neck Treatment Key Players in North America (2019-2020)
6.3 North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2015-2020)
6.4 North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size (2015-2020)
7.2 Squamous Cell Carcinoma of the Head and Neck Treatment Key Players in Europe (2019-2020)
7.3 Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2015-2020)
7.4 Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2015-2020)
8 China
8.1 China Squamous Cell Carcinoma of the Head and Neck Treatment Market Size (2015-2020)
8.2 Squamous Cell Carcinoma of the Head and Neck Treatment Key Players in China (2019-2020)
8.3 China Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2015-2020)
8.4 China Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Squamous Cell Carcinoma of the Head and Neck Treatment Market Size (2015-2020)
9.2 Squamous Cell Carcinoma of the Head and Neck Treatment Key Players in Japan (2019-2020)
9.3 Japan Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2015-2020)
9.4 Japan Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Squamous Cell Carcinoma of the Head and Neck Treatment Market Size (2015-2020)
10.2 Squamous Cell Carcinoma of the Head and Neck Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2015-2020)
11 India
11.1 India Squamous Cell Carcinoma of the Head and Neck Treatment Market Size (2015-2020)
11.2 Squamous Cell Carcinoma of the Head and Neck Treatment Key Players in India (2019-2020)
11.3 India Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2015-2020)
11.4 India Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size (2015-2020)
12.2 Squamous Cell Carcinoma of the Head and Neck Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2015-2020)
12.4 Central & South America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Sanofi
13.1.1 Sanofi Company Details
13.1.2 Sanofi Business Overview
13.1.3 Sanofi Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
13.1.4 Sanofi Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020))
13.1.5 Sanofi Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
13.2.4 Pfizer Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Eli Lilly
13.3.1 Eli Lilly Company Details
13.3.2 Eli Lilly Business Overview
13.3.3 Eli Lilly Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
13.3.4 Eli Lilly Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020)
13.3.5 Eli Lilly Recent Development
13.4 Bristol-Myers Squibb
13.4.1 Bristol-Myers Squibb Company Details
13.4.2 Bristol-Myers Squibb Business Overview
13.4.3 Bristol-Myers Squibb Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
13.4.4 Bristol-Myers Squibb Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020)
13.4.5 Bristol-Myers Squibb Recent Development
13.5 Merck
13.5.1 Merck Company Details
13.5.2 Merck Business Overview
13.5.3 Merck Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
13.5.4 Merck Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020)
13.5.5 Merck Recent Development
13.6 Bayer
13.6.1 Bayer Company Details
13.6.2 Bayer Business Overview
13.6.3 Bayer Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
13.6.4 Bayer Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020)
13.6.5 Bayer Recent Development
13.7 Fresenius
13.7.1 Fresenius Company Details
13.7.2 Fresenius Business Overview
13.7.3 Fresenius Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
13.7.4 Fresenius Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020)
13.7.5 Fresenius Recent Development
13.8 Teva Pharmaceutical
13.8.1 Teva Pharmaceutical Company Details
13.8.2 Teva Pharmaceutical Business Overview
13.8.3 Teva Pharmaceutical Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
13.8.4 Teva Pharmaceutical Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020)
13.8.5 Teva Pharmaceutical Recent Development
13.9 AB SCIENCE
13.9.1 AB SCIENCE Company Details
13.9.2 AB SCIENCE Business Overview
13.9.3 AB SCIENCE Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
13.9.4 AB SCIENCE Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020)
13.9.5 AB SCIENCE Recent Development
13.10 AbbVie
13.10.1 AbbVie Company Details
13.10.2 AbbVie Business Overview
13.10.3 AbbVie Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
13.10.4 AbbVie Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020)
13.10.5 AbbVie Recent Development
13.11 Acceleron Pharma
10.11.1 Acceleron Pharma Company Details
10.11.2 Acceleron Pharma Business Overview
10.11.3 Acceleron Pharma Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
10.11.4 Acceleron Pharma Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020)
10.11.5 Acceleron Pharma Recent Development
13.12 Astellas Pharma
10.12.1 Astellas Pharma Company Details
10.12.2 Astellas Pharma Business Overview
10.12.3 Astellas Pharma Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
10.12.4 Astellas Pharma Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020)
10.12.5 Astellas Pharma Recent Development
13.13 AstraZeneca
10.13.1 AstraZeneca Company Details
10.13.2 AstraZeneca Business Overview
10.13.3 AstraZeneca Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
10.13.4 AstraZeneca Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020)
10.13.5 AstraZeneca Recent Development
13.14 Sumitomo Dainippon Pharma
10.14.1 Sumitomo Dainippon Pharma Company Details
10.14.2 Sumitomo Dainippon Pharma Business Overview
10.14.3 Sumitomo Dainippon Pharma Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
10.14.4 Sumitomo Dainippon Pharma Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020)
10.14.5 Sumitomo Dainippon Pharma Recent Development
13.15 GENERAL ELECTRIC COMPANY
10.15.1 GENERAL ELECTRIC COMPANY Company Details
10.15.2 GENERAL ELECTRIC COMPANY Business Overview
10.15.3 GENERAL ELECTRIC COMPANY Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
10.15.4 GENERAL ELECTRIC COMPANY Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020)
10.15.5 GENERAL ELECTRIC COMPANY Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Squamous Cell Carcinoma of the Head and Neck Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Squamous Cell Carcinoma of the Head and Neck Treatment Revenue
Table 3. Ranking of Global Top Squamous Cell Carcinoma of the Head and Neck Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Salivary Gland
Table 6. Key Players of Oral & Oropharyngeal
Table 7. Key Players of Nasal Cavity & Paranasal Sinus
Table 8. Key Players of Nasopharyngeal
Table 9. Key Players of Laryngeal & Hypo pharyngeal
Table 10. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Regions (2015-2020)
Table 14. Global Squamous Cell Carcinoma of the Head and Neck Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Squamous Cell Carcinoma of the Head and Neck Treatment Market Growth Strategy
Table 20. Main Points Interviewed from Key Squamous Cell Carcinoma of the Head and Neck Treatment Players
Table 21. Global Squamous Cell Carcinoma of the Head and Neck Treatment Revenue by Players (2015-2020) (Million US$)
Table 22. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Players (2015-2020)
Table 23. Global Top Squamous Cell Carcinoma of the Head and Neck Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment as of 2019)
Table 24. Global Squamous Cell Carcinoma of the Head and Neck Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Product Solution and Service
Table 27. Date of Enter into Squamous Cell Carcinoma of the Head and Neck Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2015-2020) (Million US$)
Table 30. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Share by Type (2015-2020)
Table 31. Global Squamous Cell Carcinoma of the Head and Neck Treatment Revenue Market Share by Type (2021-2026)
Table 32. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Share by Application (2015-2020)
Table 33. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2015-2020) (Million US$)
Table 34. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Share by Application (2021-2026)
Table 35. North America Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Market Share (2019-2020)
Table 37. North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2015-2020) (Million US$)
Table 38. North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Type (2015-2020)
Table 39. North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2015-2020) (Million US$)
Table 40. North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Application (2015-2020)
Table 41. Europe Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Market Share (2019-2020)
Table 43. Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Type (2015-2020)
Table 45. Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Application (2015-2020)
Table 47. China Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Revenue (2019-2020) (Million US$)
Table 48. China Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Market Share (2019-2020)
Table 49. China Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2015-2020) (Million US$)
Table 50. China Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Type (2015-2020)
Table 51. China Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2015-2020) (Million US$)
Table 52. China Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Application (2015-2020)
Table 53. Japan Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Market Share (2019-2020)
Table 55. Japan Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Type (2015-2020)
Table 57. Japan Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Market Share (2019-2020)
Table 61. Southeast Asia Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Type (2015-2020)
Table 63. Southeast Asia Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Application (2015-2020)
Table 65. India Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Revenue (2019-2020) (Million US$)
Table 66. India Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Market Share (2019-2020)
Table 67. India Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2015-2020) (Million US$)
Table 68. India Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Type (2015-2020)
Table 69. India Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2015-2020) (Million US$)
Table 70. India Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Market Share (2019-2020)
Table 73. Central & South America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Type (2015-2020)
Table 75. Central & South America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Application (2015-2020)
Table 77. Sanofi Company Details
Table 78. Sanofi Business Overview
Table 79. Sanofi Product
Table 80. Sanofi Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020) (Million US$)
Table 81. Sanofi Recent Development
Table 82. Pfizer Company Details
Table 83. Pfizer Business Overview
Table 84. Pfizer Product
Table 85. Pfizer Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020) (Million US$)
Table 86. Pfizer Recent Development
Table 87. Eli Lilly Company Details
Table 88. Eli Lilly Business Overview
Table 89. Eli Lilly Product
Table 90. Eli Lilly Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020) (Million US$)
Table 91. Eli Lilly Recent Development
Table 92. Bristol-Myers Squibb Company Details
Table 93. Bristol-Myers Squibb Business Overview
Table 94. Bristol-Myers Squibb Product
Table 95. Bristol-Myers Squibb Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020) (Million US$)
Table 96. Bristol-Myers Squibb Recent Development
Table 97. Merck Company Details
Table 98. Merck Business Overview
Table 99. Merck Product
Table 100. Merck Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020) (Million US$)
Table 101. Merck Recent Development
Table 102. Bayer Company Details
Table 103. Bayer Business Overview
Table 104. Bayer Product
Table 105. Bayer Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020) (Million US$)
Table 106. Bayer Recent Development
Table 107. Fresenius Company Details
Table 108. Fresenius Business Overview
Table 109. Fresenius Product
Table 110. Fresenius Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020) (Million US$)
Table 111. Fresenius Recent Development
Table 112. Teva Pharmaceutical Business Overview
Table 113. Teva Pharmaceutical Product
Table 114. Teva Pharmaceutical Company Details
Table 115. Teva Pharmaceutical Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020) (Million US$)
Table 116. Teva Pharmaceutical Recent Development
Table 117. AB SCIENCE Company Details
Table 118. AB SCIENCE Business Overview
Table 119. AB SCIENCE Product
Table 120. AB SCIENCE Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020) (Million US$)
Table 121. AB SCIENCE Recent Development
Table 122. AbbVie Company Details
Table 123. AbbVie Business Overview
Table 124. AbbVie Product
Table 125. AbbVie Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020) (Million US$)
Table 126. AbbVie Recent Development
Table 127. Acceleron Pharma Company Details
Table 128. Acceleron Pharma Business Overview
Table 129. Acceleron Pharma Product
Table 130. Acceleron Pharma Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020) (Million US$)
Table 131. Acceleron Pharma Recent Development
Table 132. Astellas Pharma Company Details
Table 133. Astellas Pharma Business Overview
Table 134. Astellas Pharma Product
Table 135. Astellas Pharma Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020) (Million US$)
Table 136. Astellas Pharma Recent Development
Table 137. AstraZeneca Company Details
Table 138. AstraZeneca Business Overview
Table 139. AstraZeneca Product
Table 140. AstraZeneca Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020) (Million US$)
Table 141. AstraZeneca Recent Development
Table 142. Sumitomo Dainippon Pharma Company Details
Table 143. Sumitomo Dainippon Pharma Business Overview
Table 144. Sumitomo Dainippon Pharma Product
Table 145. Sumitomo Dainippon Pharma Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020) (Million US$)
Table 146. Sumitomo Dainippon Pharma Recent Development
Table 147. GENERAL ELECTRIC COMPANY Company Details
Table 148. GENERAL ELECTRIC COMPANY Business Overview
Table 149. GENERAL ELECTRIC COMPANY Product
Table 150. GENERAL ELECTRIC COMPANY Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2015-2020) (Million US$)
Table 151. GENERAL ELECTRIC COMPANY Recent Development
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Type: 2020 VS 2026
Figure 2. Salivary Gland Features
Figure 3. Oral & Oropharyngeal Features
Figure 4. Nasal Cavity & Paranasal Sinus Features
Figure 5. Nasopharyngeal Features
Figure 6. Laryngeal & Hypo pharyngeal Features
Figure 7. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Specialty Clinics Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Squamous Cell Carcinoma of the Head and Neck Treatment Report Years Considered
Figure 12. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Players in 2019
Figure 17. Global Top Squamous Cell Carcinoma of the Head and Neck Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Squamous Cell Carcinoma of the Head and Neck Treatment Revenue in 2019
Figure 19. North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
基底細胞がん（BCC）治療薬の世界市場（～2026年） Basal Cell Carcinoma (BCC) is a form of non-melanocytic skin cancer that arises from basal cells, the small, round cells present in the lower epidermis. Around 85% of BCCs occur on the face, head and neck. BCCs usually do not spread or metastasize to other parts of body, they become life threatening…- 高度腎細胞癌治療薬の世界市場（～2026年） Advanced renal cell carcinoma is associated with a type of kidney cancer that appears in the covering of the proximal complex tubule. The convoluted tubule is a very small part of tubes in the kidney that helps in transportation of unwanted particles from the blood to the urine. Advanced renal cell …
- 口腔がん治療の世界市場（～2026年） Oral cancer, also known as mouth cancer, is a type of head and neck cancer and is any cancerous tissue growth located in the oral cavity. It may arise as a primary lesion originating in any of the tissues in the mouth, by metastasis from a distant site of origin, or by extension from a neighboring a…
- 腎細胞がん治療薬の世界市場（～2026年） Renal cell carcinoma (RCC) is a kidney cancer that originates in the lining of the proximal convoluted tubule, a part of the very small tubes in the kidney that transport primary urine. RCC is the most common type of kidney cancer in adults, responsible for approximately 90–95% of cases.The drug is …
- 副腎皮質がん治療の世界市場（～2026年） Adrenocortical carcinoma (ACC) is a rare disease caused by cancerous growth in the adrenal cortex, which is the outer layer of the adrenal glands. The adrenal glands lie on top of the kidneys. They play a major role in the endocrine system, which is the system that produces and regulates hormones. T…